M
MBX
MBX Biosciences Inc
62.00
-1.57-2.47%After Hours: 62.00 0.00 0.00%19:34 07/24 EDT
OPEN/PREV CLOSE64.22/63.57
TODAY RANGE60.85-66.66
VOL500.94K
MARKET CAP2.95B
52 WEEK RANGE9.63-66.66
AVG VOL (3M)852.86K
% TURNOVER1.05%
TURNOVER--
P/E (TTM)-28.0784
% RANGE9.14%
EPS(TTM)-2.2081
P/E(FORWARD)-22.3827
P/B6.74
BVPS9.20
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.23B
SHARES OUTSTANDING47.60M
NEXT EARNINGS08/05-08/10
FREE FLOAT36.02M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·1d ago
MBX Biosciences price target raised to $90 from $60 at UBS
Simply Wall St·3d ago
MBX Biosciences (MBX) Leadership Shake-Up: How Might New Management Reframe Its Investment Narrative?
Simply Wall St·07/17 19:23
Is MBX Biosciences (MBX) Fairly Valued As New Leadership Takes Charge?
Benzinga·07/17 14:09
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday
TipRanks·07/15 19:20
Analysts’ Top NA Picks: SanDisk Corp (SNDK), MBX Biosciences, Inc. (MBX)
Reuters·07/15 12:30
ATTOVIA THERAPEUTICS APPOINTS JOHN W. SMITHER TO BOARD OF DIRECTORS
Simply Wall St·07/14 14:35
How MBX Biosciences’ New CEO-Chairman Structure Could Reframe the MBX Investment Narrative
Seeking Alpha·07/14 09:01
Biggest stock movers Tuesday: TSEM, ERIC, and more
TipRanks·07/13 23:45
Closing Bell Movers: Trex up 6% after positive Q2 pre-announcement
TipRanks·07/13 22:08
MBX Biosciences Announces CEO Transition and Leadership Updates
Benzinga·07/13 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
Dow Jones·07/13 21:01
MBX Biosciences Names Steve Hoerter Chief Executive